The United States Food and Drug Administration suspends a gene therapy study and reviews 28 others after the death of a patient.
- AP via CNN
- The Food and Drug Administration has approved the first treatment that genetically engineers patients' own blood cells to destroy acute lymphoblastic leukemia. The approval makes Novartis the proprietor of the first gene therapy to hit the U.S. market.
- The United States Food and Drug Administration approves marketing of a cooling cap system to reduce hair loss in female breast cancer patients during chemotherapy. The DigniCap scalp cooling system, a product first available in Sweden in the 1990s, produces near-freezing temperatures that make it harder for cancer-fighting drugs to reach and harm hair follicles.
- The United States Food and Drug Administration (FDA) lifts the 32-year-old, lifetime ban on blood donations from gay and bisexual men. Men can donate if they haven't had sex with another man in the previous year. The FDA stance is in line with other countries, such as Australia, Brazil, Canada, New Zealand, and the U.K., and is consistent with rules on recent blood transfusion or accidental exposure to another individual's blood.
- The United States Food and Drug Administration approves the Merck & Co. drug, Bridion, that reverses the effects of muscle relaxants used during surgery.
- The U.S. Food and Drug Administration orders R. J. Reynolds Tobacco Company to stop further U.S. sale and distribution of four cigarette products because they may be more dangerous than similar older cigarettes.